Management of CMV retinitis in HIV infected patients.
Katlama
C
C
Department of Infectious and Tropical Diseases, Hôpital Pitlé-Salpêtrière, Paris, France.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000998:Antiviral Agents / Q000627:therapeutic use; D000077404:Cidofovir; D002986:Clinical Trials as Topic; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy*; D003596:Cytosine / Q000031:analogs & derivatives / Q000627:therapeutic use; D017245:Foscarnet / Q000627:therapeutic use; D015774:Ganciclovir / Q000627:therapeutic use; D006147:Guanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D011355:Prodrugs / Q000627:therapeutic use; D011446:Prospective Studies; D012008:Recurrence
D000998:Antiviral Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D011355:Prodrugs; D017245:Foscarnet; D006147:Guanine; D003596:Cytosine; C063638:lobucavir; D000077404:Cidofovir; D015774:Ganciclovir